Likewise, S100A8 and S100A9, also known as myeloid-related protein 8 and 14 (MRP8 and MRP14), respectively, are emerging preclinical biomarkers upregulated in various inflammatory disease models including IBD [24–28]. This evidence concerns the gene S100A9 and inflammatory bowel disease.